Search

In regenerative medicines and therapeutics, fibroblasts can offer significant advantages over stem cells, says Hamid Khoja

A new method for muting malaria turns one of the parasite’s proteins into a self-destruction device

It’s been a busy time for infectious disease vaccine news in Europe.

Academia-industry collaboration doesn’t have to be difficult; we just need to appreciate one another’s differences.

Cell and gene therapy manufacturers need to make better plasmid design decisions with commercialization in mind.

The DNDi is doing incredible work across the world. In this digital feature, we explore a portion of these open science efforts.

Single-use technology continues to evolve; single-use bags are now a robust alternative to using bottles in freeze and thaw.

What links the DNDi and one of Google’s most futuristic AI assets? We get the story from DeepMind’s protein premier.

This is the story of how DNDi put forward a new model for collaborative, open science.

What are the biggest lessons that the pharma industry has learned from the COVID-19 pandemic?